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Abstract
Nocturnal enuresis is a condition with complex etiology affecting plenty of 
children and families. Even though multifarious clinical trials and studies have been 
designed and completed, some inconclusive results on nocturnal enuresis confuse 
clinicians. This article aims to provide useful information for clinicians by summa-
rizing the existing evidence on nocturnal enuresis and discussing the effectiveness 
and safety of different treatments. Nocturnal enuresis mainly results from the 
disorders related to central nervous system, which may cause nocturnal polyuria, 
nighttime bladder capacity decline, arousal disorder, and various accompanying 
diseases. We discussed the efficacy and safety of different treatments for mono-
symptomatic nocturnal enuresis, including standard therapies, simple behavioral 
interventions, complex behavioral interventions, alarm therapy, desmopressin and 
other drugs, biofeedback therapy, electrical stimulation, acupuncture, Chinese 
herbal medicine, massage, and so on. Alarm is still the most effective single therapy 
with lower relapse rate. Desmopressin has efficacy mainly in children with noctur-
nal polyuria. Children with detrusor overactivity or decreasing functional bladder 
capacity can choose anticholinergics. Additionally, tricyclic drugs, biofeedback 
therapy, electrical stimulation, acupuncture, massage, and so on are therapeutic 
options for children with nocturnal enuresis.
Keywords: nocturnal enuresis, alarm, desmopressin, behavioral interventions, 
acupuncture
1. Introduction
Nocturnal enuresis (NE) is a common disease that pediatricians often encounter. 
It is defined as an intermittent involuntary micturition during sleep in children 
over 5 years of age with at least two episodes per week and duration of more than 3 
months [1]. Basically, NE is divided into non-monosymptomatic nocturnal enuresis 
(NMNE) and monosymptomatic nocturnal enuresis (MNE) according to whether 
there are daytime lower urinary tract symptoms. On the other hand, it is also 
classified into primary nocturnal enuresis (PNE) and secondary nocturnal enuresis 
(SNE) according to whether or not the duration of dry days is less than 6 months 
[1]. Secondary NE requires clinicians to identify and evaluate the diseases which 
NE is secondary to and treat them first. In PNE, NMNE usually means that children 
have more complex bladder dysfunction or other potential pathology and need to be 
referred to a specialist for further diagnosis and treatment. Although some children 
with MNE can be self-healing and the prevalence gradually decrease with age [2], 
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most treatments for NE cannot achieve high cure rates and may cause high relapse 
rates. This may result from the complexity and uncertainty of the etiology of NE 
and the use of inappropriate treatment.
2. Epidemiology
According to Jain et al.’s review, the prevalence of MNE varies from 3.8 to 
18.9% in different countries [2]. The risk factors related to NE reported in differ-
ent studies include constipation, positive family history, obstructive respiratory 
disorder, deep sleep, corporal punishment at school, urinary tract infection, etc. 
[3–6]. However, the effect of each factor on NE varies from study to study, and no 
universal conclusion is drawn. The results from different studies may be contra-
dictory. For example, a few researches reported that the prevalence of NE was sig-
nificantly higher in boys than the one in girls [3, 7], while other studies draw the 
opposite conclusion that girls’ prevalence is higher [8]. The potential reasons for 
the contradiction of results in different studies performed in different countries 
may be related to the difference in diagnostic criteria followed by each survey, 
sample size, sampling method, questionnaire design, and cultural background in 
different regions. According to Wen’s survey about NE in Chinese children, the 
overall prevalence was 4.07%, which is much lower than counterparts in other 
countries [9]. In it, Dr. Wen reported that Chinese parents would wake their 
children to void once they found children’s dysphoria due to the fullness of the 
bladder. Besides, he also found that Chinese parents were more likely to withdraw 
the diaper for their children as early as possible, which is believed to be helpful for 
the children to build normal urination habits. Similar to the mechanism of alarm 
therapy, these actions may have a positive effect to promote the establishment 
of reflex between bladder filling feeling and urination. It is important to analyze 
epidemiological data, which may help us to understand the importance of the 
children and their parents’ behavior and other complex physiological, pathologi-
cal, and social psychological elements involved in the prevalence of NE.
3. Clinical diagnosis and treatment algorithm
There are a few diagnosis and treatment algorithms of NE proposed by the 
International Children’s Continence Society (ICCS), the International Continence 
Society (ICS), and some other literatures with similarities and differences. In this 
part, the algorithm of the ICCS’s practical consensus guideline is introduced and 
modified.
NE has many possible causes: genetic factors, renal physiological factors, defi-
ciency of antidiuretic hormone (ADH, vasopressin) leading to nocturnal polyuria, 
bladder dysfunction, arousal disorder, maturation delay, circadian rhythm disorder, 
etc. Moreover, many associated diseases such as obstructive sleep-disordered 
breathing, constipation, fecal incontinence, attention deficit disorder (ADD) and 
attention deficit hyperactivity disorder (ADHD), obesity, psychological problems, 
etc. can also be seen in children with NE. These associated diseases should be 
identified in the clinical evaluation and be treated first. For children without those 
conditions, the increase in nocturnal urine production and nighttime bladder 
capacity reduction are the two main prototypes. To provide an outline in the diag-
nosis and management of NE, we build an algorithm after summarizing available 
guidelines. Figure 1 is the clinical diagnosis and treatment algorithm adapted from 
the guideline of Walle et al [10]:
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1. Clinical management tool is a medical history and symptoms collection form 
(see [10]).
2. Voiding diary (bladder diary) is not necessary.
3. After MNE is diagnosed, the 2012 guideline recommends directly the alarm 
and desmopressin treatment options. John Michael’s review in 2014 recom-
mends 6 weeks of urotherapy first and then evaluating the child to decide 
whether to take alarm or desmopressin [11].
4. EBC: expected bladder capacity, calculated as {30 + (age in years × 30)} in 
milliliters.
5. MVV: maximum voided volume, the largest urine volume of 24 h (see part 
bladder diary for details).
Figure 1. 
Nocturnal enuresis algorithm (modified from Walle, 2012).
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4. Treatment
4.1 Urotherapy
According to the 2006 ICCS’s standardized terminology of lower urinary tract 
(LUT) function, urotherapy is defined as a nonsurgical and nonpharmacological 
treatment for LUT dysfunction [1]. It includes standard therapy which means the 
therapy is noninterventional and has specific interventions.
4.1.1 Standard therapy
The standard therapy usually has these components as below:
1. Health education. Health education refers to providing parents basic informa-
tion about normal LUT function and the causes, risk factors, different treat-
ments, and their implementation of MNE [1]. The clinicians should emphasize 
that the condition is common and can be healed by itself and that parents 
should have a positive attitude instead of thinking enuresis as a shame because 
this helps children to establish their motivation for active participation and 
reduce damage to their self-esteem, which is the key to treatment [12].
2. Lifestyle advice. Develop healthy drinking and eating habits: avoid foods or bever-
ages that have a diuretic effect, such as theophylline or caffeine; eat early in the 
evening, with less oil and less salt; and no more water or food and fruit rich in fluid 
at least 2 h before going to bed. These all avoid excessive nighttime fluids in body 
which may lead to overmuch urine production during the night. However, for 
children with MNE, fluid restriction may have a risk of reducing bladder capacity 
resulting in a decrease in the ratio of bladder capacity to nocturnal urine output, 
and so nocturnal enuresis increases [13]. Therefore, adequate fluid intake during 
the day is important, especially during the morning and early afternoon hours 
[14]. It is also good for cultivating the child’s feeling of bladder fullness. Moreover, 
a research indicates that holding exercises can increase the maximum voided 
volume of children with MNE, so it is better not to be active after dinner [15].
3. Developing regular voiding and bowel habits. As the ICCS recommended, 
children should develop a good habit of regular urination during the day and 
schedule to urinate before going to bed and in the early morning after wak-
ing up. The daily routine of micturition should be comprised of once in the 
morning, at least twice during school hours, and once each after school, at 
dinner, and before going to bed, with totally less than seven urinations dur-
ing daytime [14]. Besides, parents should instruct the child to use a comfort-
able voiding posture to relax the pelvic floor muscles—and that means sitting 
on the toilet safely with the bottom and feet supported. Constipation is a 
common concomitant disease in children with NE, especially with NMNE. It 
is recommended to eat more foods rich in dietary fiber and develop regular 
bowel movements every day, best after breakfast. Based on current evidence, 
medication can be used to soften children’s stools if necessary [14].
4. Voiding diary or bladder diary (VD or BD). According to the 2012 ICCS’s practi-
cal consensus guidelines for MNE’s management [10], BD is recommended to 
assess the children’s voiding habit, especially for the families in which parents 
are unclear about children’s voiding history. The most important function of 
BD is to evaluate the bladder capacity of children through daytime diary and 
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to assess the presence of nocturnal polyuria (NP) through nighttime diary. It 
is also helpful to distinguish NMNE through finding out daytime polyuria, 
stress urinary incontinence, urgency urinary incontinence, etc. A daytime diary 
should include at least fluid intake time, urination time, fluid intake volume, 
urination volume, and the occurrence of urinary incontinence and exclude the 
first urination after getting up in the morning. The recording time should be at 
least 3–4 consecutive days. Children attending school can choose to record two 
consecutive weekends [10]. In daytime diary, the most important thing that 
requires clinicians’ attention is the largest urinated volume which can indicate 
the child’s bladder capacity. It can be determined if the bladder capacity is 
reduced or increased when the maximum voided volume is <65% or >130% 
expected bladder capacity (EBC’s calculation formula is shown in Figure 1). 
The nighttime diary should include at least urination time (if the child gets up to 
the toilet), urination volume, diaper weight overnight, first urination volume 
after getting up in the morning, dry night or not (there is any enuresis or not), 
and whether there is bowel movement that day. The recording time should be at 
least seven consecutive nights [10]. What the nighttime diary can tell the clini-
cians is the child’s amount of urine produced at night by adding first urination 
after getting up in the morning, the nighttime diaper weight, and nocturnal 
urination volume to the toilet. If the total nighttime urine output exceeds 130% 
EBC, it is determined as nighttime polyuria (NP). Through analyzing indi-
vidual BD, children with MNE can be classified into one of the four subtypes 
as shown in Figure 1. Then the corresponding treatment could be determined. 
In addition, by calculating a child’s body surface area, we can find whether the 
24-h urine volume >2 L/m2, which means the child has polyuria; by observing a 
child’s water taking, we can know if the child has polydipsia which is considered 
as a predictor of diabetes or kidney disease. It is worth noting that children with 
these conditions are not suitable to take desmopressin.
4.1.2 Specific interventions
Specific interventions comprise behavioral modification and nonbehavioral 
strategies including pelvic muscle floor training, biofeedback, electrical stimula-
tion, etc. [1]. And the behavioral interventions can also be divided into simple 
and complex strategies based on whether it is a single action or they are composite 
interventions [16] (Table 1).
Simple behavioral Interventions Reward systems
Lifting or waking the children at night to urinate1
Bladder training2
Fluid restriction
Cleanliness training
Complex behavioral interventions Dry bed training (DBT)
Full-spectrum home training (FSHT)
Arousal therapy
1Lifting and waking therapy includes lifting with or without password and waking randomly or to a certain time.
2Bladder training includes retention control training, pelvic floor muscle training, sphincter control exercises, and 
stream interruption exercises.
Table 1. 
Categories of behavioral interventions.
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4.1.2.1 Simple behavioral interventions
Most of the simple behavioral interventions were initially presented in some 
early literatures, because the effects of first-line treatment on NE had not yet been 
determined at the time. They are often used in clinical treatment, but the efficacy 
is controversial since it lacks high-quality evidence. A systematic review about the 
efficacy and safety of simple behavioral interventions for NE has been published in 
the Cochrane Library. Unfortunately, only limited evidence is available. For most 
interventions only a single clinical trial was included, and therefore the data cannot 
be combined for meta-analysis except for the comparison between bladder training 
and alarm [16]. Furthermore, some other important limitations about the clinical 
trials were discussed in this review: for children with NE included in the trials, 
MNE and NMNE were not further distinguished; most trials had methodological 
deficiencies, and more than half of the trials reporting continuous outcomes did 
not report SDs; the trials’ sample size was small, risk of bias was high, and the 
confidence interval was too wide; since there is a lack of long-term follow-up after 
the end of treatment, no data were available to assess the long-term efficacy of the 
interventions [16]. The following is a summary of this review’s conclusion which 
needs to be cautiously referenced.
In the simple behavioral interventions referring to reward systems, lifting or 
waking the children, bladder training, and fluid restriction (cleanliness training was 
not reviewed), though all of them were more effective statistically than the control 
group, none of them had a better effect than others at the end of the treatment. 
When compared with alarm or different drugs, they were usually less effective 
except for bladder training which has no significant difference with drugs [16]. In 
terms of safety, adverse events were not reported in the included trials.
Bladder training is a behavioral therapy aiming to increase bladder capac-
ity and strengthen the control of bladder in children. According to the review, 
bladder training seemed to be superior to the nonactive movements group in 
gaining less mean wet nights at the end of the treatment. However, there was 
no difference in the number of children who did not achieve 14 dry nights [16]. 
Another prospective trial further revealed that the basic bladder training’s effects 
mostly were pronounced after the third month of treatment for the MNE children 
who did not receive any previous treatment. Therefore, for children who are not 
strongly willing to accept behavioral interventions, early administration of alarm 
or desmopressin is necessary [17]. But it seems to have good efficacy in children 
with NMNE [18].
Lifting without password is a controversial intervention because it allows the 
children to urinate while asleep, but it is useless to reduce the occurrence of noctur-
nal enuresis [19]. Being consistent with the conclusions of this review, a study also 
showed that the lifting without password group had a significantly higher propor-
tion in the number of dry children than the control group and was even superior 
to lifting with password group and rewards group. In terms of long-term effect, 
both lifting groups had more dry children than the two other groups during 3 years 
follow-up [20].
4.1.2.2 Complex behavioral interventions
Dry bed training (DBT) is the oldest complex behavioral interventions with 
a multicomponent package of nighttime waking schedule, cleanliness training, 
reinforcement techniques, and other interventions. It has different versions and a 
few adapted versions with some components removed [21]. Full-spectrum home 
training (FSHT) is a combination with alarm, cleanliness training, and retention 
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control training in the daytime. To maximize the effect, the FSHT needs to be 
overlearned (giving extra fluids at bedtime after successfully  becoming dry). 
Specific implementation steps of DBT and FSHT have been described by Brown 
and Glazener [22, 23]. In a Cochrane review of NE, complex behavioral inter-
ventions were compared with control, alarm, and other complex behavioral 
interventions. Moreover, complex behavioral interventions removing alarm 
were compared with control, alarm, and complex behavioral interventions 
supplemented by alarm. The conclusions were that DBT or FSHT was better 
than control in efficacy and relapse rate and marginally superior to alarm alone. 
Either complex behavioral interventions removing alarm or control intervention 
was inferior to alarm alone or complex behavioral interventions supplemented 
by alarm. There is no evidence for the comparison between complex behavioral 
interventions removing alarm and control. Additionally, adverse events were not 
described by the trials [23]. Unfortunately, the included studies in the systematic 
review have some limitations including small scale, small quantity, and poor 
quality. Besides, it has to be mentioned that the interventions are heavy burdens 
on families.
Alarm and reward system are the components of arousal therapy/training, 
which was reported to have a high efficacy and low relapse rate in an early literature 
[24]. However, they have not been recommended by the guideline [10] because 
there is not enough clinical evidence, which is similar to FSHT [25].
4.1.2.3 Nonbehavioral interventions
Biofeedback therapy and electrical stimulation therapy were originally used to 
treat voiding dysfunction, and now they have been tried to treat refractory MNE or 
PNE with a reported good efficacy. Dr. Hoekx and his colleagues prospectively evalu-
ated the effect of bladder biofeedback in 21 boys and 3 girls (mean age 10.4 years). 
After treatment 17/24 patients showed good response that means they achieved totally 
dry. During the 60-month follow-up, 4 patients were lost, 15 were dry at night, and 
4 continued bed-wetting. The proportion of children with small bladder capacity in 
responders is much less than the one in non-responders [26]. In a randomized clinical 
trial published in 2015, 54 children with PNE were included and randomly divided 
into interferential (IF) electrical stimulation group and control group. A responding 
rate was reported as 55.5 and 22% in the IF and control group at the 1-year follow-up 
(P = 0.01), respectively. In terms of the mean number of dry nights per week and 
the mean improvement score, the IF group was superior compared to control group. 
Additionally, no adverse events were reported [27]. In another trial, children with 
refractory MNE were randomly assigned to intra-anal biofeedback with behavioral 
therapy, electrical stimulation with behavioral therapy, and pelvic floor muscle train-
ing groups. The trial stated a total efficacy of three groups in the outcomes and that 
intra-anal ES group was superior to BF training group. But in these three outcomes, 
the method to assess nighttime bladder capacity with morning first urine volume is 
not accurate [28]. In short, there is no adequate clinical evidence to determine the 
therapeutic effectiveness of these NE treatments (Table 2).
Nonbehavioral interventions Biofeedback (BF)1
Electrical stimulation (ES)
1Including bladder biofeedback and intra-anal biofeedback
Table 2. 
Categories of nonbehavioral interventions.
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4.2 Alarm
Alarm therapy, also known as enuretic alarm devices (EADs) or enuresis alarm 
treatment (EA), is a kind of therapy with sufficient evidence which shows a higher 
response rate and a superior long-time success than the control or other therapies. 
Although its relapse rate is still a little high, the addition of overlearning and dry 
bed training or avoiding penalties can reduce the rate by nearly half [29]. In terms 
of different types of alarms, there was no enough evidence to draw conclusions, 
neither did the comparison between alarm and other behavioral therapies [29]. Two 
other Cochrane reviews revealed that alarm had better effects than simple behav-
ioral interventions, but not when compared with complex behavioral therapies 
[16, 23]. Some researchers believed the effect of alarm might be weakened if only 
the parents were waked by the alarm instead of the children. A result from Tsuji’s 
study showed whether the parents or children themselves are waked by the alarm 
or the effectiveness of alarm is equal [30]. Apos E. et al.’s study published in 2018 
stated excellent effects of alarm therapy for MNE, NMNE, PNE, and SNE children 
using alarm therapy and especially for NMNE children [31]. The ICCS guideline 
also recommended that the alarm should be considered as the therapeutic option 
for every child. Furthermore, those children who have motivated parents should be 
given a priority [14].
It has to be mentioned that alarm does not have an immediate effect. Normally, it 
often needs to take a period of time to achieve the expected efficacy. The appropriate 
course recommended by the ICCS is 2–3 months until children achieve 14 consecu-
tive dry nights or the effect is not good [14]. Similarly, the ICS’s recommendation is 
to evaluate the efficacy of alarm after at least 6–8 weeks [12]. It also states that the 
efficacy will increase with treatment duration; however, the ideal course of alarm has 
not been introduced [12]. In one study, a total of 455 children with PMNE were ran-
domly divided into three groups and received 3, 4, and 5 months of uninterrupted 
alarm treatment, respectively. The results showed that children with 16–20 weeks’ 
treatment had better curative effect [32]. Unfortunately, this study did not observe 
the effect with a longer follow-up. So we cannot conclude if the longer treatment can 
further increase the effect of alarm. In another study, NE children who were inef-
fective after 3 months’ alarm treatment were randomized into two groups to receive 
a repeat alarm treatment for ≥3 months without interval and with an interval of 
more than 6 months, separately. The success rate in the latter group was significantly 
higher than the former, which means repeat alarm therapy with at least one interval 
may reawaken children’s response [33]. Despite the small sample size, this study may 
provide new ideas for children who have no response to alarm treatment.
The possible mechanism of alarm therapy may be a gradual establishment of 
a conditioned reflex between bladder filling and waking. Evidence showed that 
it could increase the prepulse inhibition (PPI), similar to the effect of desamino-
arginine vasopressin (dDAVP), which suggested that the alarm could also promote 
the maturation of the reflex control of NE [34]. In addition, a study reported that 
children’s daytime functional bladder capacity increased markedly after treatment 
with alarm [35]. Therefore, the efficacy of alarm on children with NE may be 
achieved through multiple effects.
4.3 Desmopressin
Desmopressin is an arginine vasopressin analog that enhances the reabsorption 
of water by the distal convoluted tubules and collecting ducts of the kidney and 
inhibits the secretion of aldosterone. Schulz-Juergensen et al.’s study published 
in 2007 showed that 1-desamino-8-d-arginine vasopressin (dDAVP) could make 
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PMNE children’s PPI upregulate to the age-related normal level. The authors offered 
a different explanation about dDAVP that it not only had a role in the kidney but 
also acted as a central neurotransmitter which has a positive effect on the delayed 
maturation of NE children’s micturition reflex [36]. According to the results of 
this study, desmopressin has the ability to cure a substantial group of children with 
NE in theory. However, it is more complicated in practice with problems of how to 
choose the potential suitable children for desmopressin therapy. Moreover, what is 
the appropriate dose and course of treatment are also big issues. To assess the effect 
of desmopressin, a number of studies have been performed. Evidence showed that 
it could significantly reduce bed-wetting by 1–2 nights per week during the treat-
ment, but there is no difference in wet nights per week compared with the placebo 
group. Additionally, when comparing with alarm therapy, lower effectiveness and 
higher subsequent relapse rate were reported in the desmopressin group according 
to a Cochrane review [37].
In general, children with nocturnal polyuria are suitable for desmopressin 
therapy. Basically, we can identify this subtype of MNE using the bladder diary. 
However, there is an evidence showing that children with NE may not present 
continuous nocturnal polyuria. Nocturnal urine production increases significantly 
on wet nights than the dry nights. Children without abnormal increase in nocturnal 
urine production do not respond to desmopressin [38]. This study revealed the 
polyuria characteristics for a subgroup of NE children and confirmed the efficacy 
of desmopressin for these children. Furthermore, some other studies also showed 
that desmopressin was not effective in children with low functional bladder capac-
ity [39] and those with abnormal bladder volume and wall thickness (BVWT) [40], 
indicating that desmopressin’s clinical use should carefully identify children with 
potential bladder dysfunction.
Referring to appropriate dose of desmopressin, there is an insufficient evidence 
to determine whether higher dose is more effective or not [37]. The recommended 
safe dose is 0.2–0.4 mg for tablets and 120–240 μg for melt formulation [14]. There 
is no enough evidence to state what is the appropriate course of treatment. Because 
of high relapse rate after treatment, it is advised to gradually reduce the drug 
dose instead of stopping it directly at the time of getting a complete response. For 
long-term safety, desmopressin is proven to be safe enough to use for several years. 
Water intoxication with hyponatremia is only a severe adverse event that needs to 
be concerned. Fluid restriction of 200 ml or less for the whole night is advised with 
desmopressin treatment [14]. Moreover, nasal spray reports more hyponatremia 
than oral formulations [41].
4.4 Pharmacotherapy (other than desmopressin)
Anticholinergic drugs are widely used for the management of NE since they 
can bind to choline receptors and produce antagonistic activity against acetylcho-
line and consequently relieve detrusor overactivity. They can be classified into M 
and N receptor blockers according to their selectivity for different receptors. M 
receptor blockers, also called as antimuscarinics, are more commonly used to treat 
NE. Generally, M receptors consist of five different subtypes, including M1, M2, 
M3, M4, and M5. Of those, M2 and M3 subtypes are mainly distributed in the blad-
der wall, and M3 has an upregulated expression in patients with overactive bladder. 
Therefore, the therapeutic mechanism of antimuscarinics is to inhibit  
the bladder M receptor, relax the detrusor, and consequently expand the bladder 
capacity. The mechanism determines that antimuscarinic drugs should be mainly 
used in treatment of NE children who are suffering from latent bladder smooth 
muscle spasm, detrusor overactivity, or decreased functional bladder capacity. 
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This kind of children usually has daytime symptoms of lower urinary tract and 
is classified as NMNE. However, some children diagnosed as MNE are also suit-
able for anticholinergic drug therapy because they have only nighttime detrusor 
overactivity or mild urinary tract symptoms during daytime. For children who do 
not respond to alarm or desmopressin therapy, anticholinergic agents are usually a 
kind of therapeutic option. The clinical application of anticholinergic drugs should 
focus on how to identify the children with indications through bladder diary and 
other diagnostic techniques. Studies to evaluate the efficacy of anticholinergic drugs 
and their combination with alarm or desmopressin on these children should be 
conducted as well.
Differing from anticholinergic drugs, the mechanism of tricyclic drugs in the 
treatment of NE is still unclear. The possible mechanism includes inhibiting rapid 
eye movement sleep to promote sleep arousal and stimulating antidiuretic hormone 
secretion. A Cochrane review showed that tricyclic drugs could reduce about one 
wet night per week, but most children relapsed after treatment which is similar to 
desmopressin and inferior to alarm [42]. In addition, most tricyclic drugs may cause 
serious side effects such as cardiotoxicity, so they are only used for the treatment 
of refractory or therapy-resistant NE. An exception is reboxetine. Neveus and his 
colleagues attempted to treat children with therapy-resistant NE using reboxetine, 
and they found that 59% of the patients reached a full response after 4 weeks of 
treatment. Moreover, during treatment, no significant cardiac toxicity was reported 
[43]. Lundmark et al. used reboxetine to treat therapy-resistant NE children 
and also achieved good results without significant cardiac adverse events [44]. 
Therefore, reboxetine may be a good therapeutic option instead of imipramine, but 
its effectiveness and safety need more clinical studies to prove.
4.5 Complementary and alternative approaches
Although a large amount of evidence has shown the effectiveness of conven-
tional treatment including alarm and pharmacotherapy on NE [31, 45], these 
approaches cannot meet all the needs of the children and their parents. It is 
reported that as high as 30% of families discontinue the treatment of alarm on their 
own reason [46]. On the other hand, the side effects related to medications bother 
both children and their family members. Therefore, a number of parents are more 
likely to seek help from complementary and alternative medicine for their children. 
Being outside of conventional medicine, complementary and alternative medicine 
includes a series of medical approaches, such as acupuncture, herbal therapy, and 
massage. Recently, an increasing evidence has shown the efficacy of complemen-
tary and alternative medicine on management of NE.
4.5.1 Acupuncture
Acupuncture, as a component of traditional Chinese medicine, has been used to 
manage a number of chronic diseases. Even though acupuncture originates in China, 
its efficacy on various urological diseases has been recognized in industrial world 
[47]. A number of studies have demonstrated the effectiveness of acupuncture in 
treatment of NE. In a single-arm trial, Bjorkstrom et al. [48] showed that an 8-week 
treatment with 20 sessions of acupuncture decreased the episodes of NE and the sleep 
arousal threshold significantly in 65 and 50% of children, respectively, at the follow-
up of 6 months. Another study further revealed that acupuncture might increase 
the nocturnal bladder capacity significantly in responders [49]. To assess the effect 
of acupuncture on NE, several systematic reviews were conducted. As presented in 
a part of Cochrane systematic review [50], Glazener et al. showed that acupuncture 
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might result in a more significant improvement for children with NE than sham inter-
vention. Moreover, acupuncture seemed to have a lower failure rate than combination 
therapy with meclofenoxate, oryzanol, and thiamine. Six years later, the updated 
Cochrane systematic review [50] demonstrated the same result. Another systematic 
review showed that acupuncture in conjunction with other treatment could reduce 
the number of NE more significantly than other treatment alone [51]. It needs to be 
mentioned that some methodological limitations have to be taken into consideration 
when we analyze the evidence. These systematic reviews included the nonrandom-
ized and quasi-randomized studies besides randomized controlled trials, which 
may weaken the level of evidence. To provide the high quality of evidence, a recent 
published systematic review excluded nonrandomized and quasi-randomized trials 
and showed that acupuncture might be more effective in management of NE than 
sham procedure or drug treatment [52]. However, some studies with the intervention 
of acupoint injection were included in the systematic review, which may make the 
results controversial. As is known, acupuncture only provides physical effect, while 
both physical and chemical effects are involved in acupoint injection.
To further provide evidence, we designed and conducted a systematic review. 
After performing a comprehensive search of medical literature, including Cochrane 
Central Register of Controlled Trials, MEDLINE, EMBASE, CBM, ClinicalTrials.gov, 
and the World Health Organization International Clinical Trials Registry Platform, 
on February 22, 2019, a total of 238 randomized controlled trials were reviewed, and  
10 of them with 953 randomized participants (441 in acupuncture group and 412 in 
control group) were included. We found that compared with the other treatment, 
acupuncture resulted in significantly higher complete response rate [OR = 2.41, 
95%CI (1.41, 4.93) P = 0.002], so did the significance when compared with conven-
tional drug, sham procedure, and herbal therapy, respectively. Moreover, although 
acupuncture did not reduce the average number of NE in comparison with other 
treatment, a significant decrease was found when compared to the sham interven-
tion [MD = −1.49, 95%CI (−2.26, −0.72) P = 0.0002]. In terms of adverse events, 
there was no significant difference between acupuncture and other treatment 
[OR = 0.62, 95%CI (0.04, 8.72) P = 0.72]. Based on our results, acupuncture may 
have a better effect in management of NE, when compared to conventional drug, 
sham procedure, and herbal therapy, respectively.
The potential mechanism of acupuncture’s effectiveness in managing NE might 
be the regulation on bladder function and secretion of antidiuretic hormone. A 
study assessed the effect of acupuncture on urodynamic parameters in children 
with NE and found acupuncture could suppress the detrusor overactivity [53]. On 
the other hand, an animal experiment showed that acupuncture could downregu-
late the concentration of arginine vasopressin in the hypothalamic paraventricular 
nucleus and upregulate the concentration of arginine vasopressin in the hypotha-
lamic supraoptic nucleus, periaqueductal gray, caudate nucleus, and nucleus raphe 
magnus [54], which may cause an antidiuretic effect.
4.5.2 Herbal therapy
Herbal therapy is an important component of traditional medicine. About 
3500 years ago, Papyrus Ebers described that cypress, juniper berries, and 
beer might be used to treat NE, which is the earliest record for the treatment 
of NE. Although there is lack of enough evidence, some herbs, such as St John’s 
wort (Hypericum perforatum), infusions of horsetail, or corn silk (Zea mays), are 
considered to be helpful to regulate bladder function [55]. Hosein et al. performed 
a double-blind randomized controlled trial to evaluate the effectiveness of chamo-
mile oil in treating NE, in which 80 patients were allocated to receive chamomile 
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oil or placebo. After 2 weeks treatment, the patients’ mean wet night frequency in 
chamomile oil group decreased from 8.2 to 5.6 nights/2 weeks, while no signifi-
cant difference was found in placebo group [56]. We hope more clinical trials can 
provide more evidence for the efficacy of herbal therapy in future.
4.5.3 Massage and chiropractic
Both massage and chiropractic are a kind of manipulative therapy acting 
on the body with appropriate pressure. The former focuses on the relaxation 
of muscle, while the latter centers on the regulation of spinal articulations. 
They can be the therapeutic options for NE since their effectiveness has been 
reported. An early study attempted to treat five children with NE using mas-
sage which pressed the acupoint located in the creases between the first and the 
second and the third phalanx of the 5th finger. After an average of 20 sessions of 
therapy, two children achieved complete recovery, and one got partial recovery 
[57]. In another study, Yuksek et al. performed an efficacy comparison of mas-
sage with oxybutynin. After 6 months treatment, 83.3% of patients in massage 
group experienced a significant improvement, which is better than 58.3% in 
oxybutynin group [58].
In a case series study, 171 children with NE were treated by chiropractic. After 
2 weeks treatment, the median episodes of NE decreased from 7.0 per week at 
baseline to 5.6 per week and further dropped to 4.0 per week at the end of treat-
ment [59]. Another finding of the study is that the more severe symptoms children 
had, the less benefit they got from the treatment, which means those with mild to 
moderate NE might be suitable for chiropractic. Reed et al. designed and conducted 
a 10-week controlled clinical trial, in which children with NE received chiropractic 
or sham intervention. After the treatment, a significant reduction was observed in 
children’s mean wet night frequency (from 9.1 to 6.7 nights/2 weeks) in chiropractic 
group. By contrast, the counterpart in sham intervention group did not change 
markedly (12.1 vs 12.2 nights/2 weeks) [60]. Van Poecke and his colleague found 
that the resolution rate within 1 year in children who received chiropractic was 
about 66.6% after analyzing the data of 33 patient records [61].
5. New about diagnostic and treatment
Enuretic bladder capacity is a big issue discussed in some recent research. 
Researchers are more likely to use the reduction in maximum voiding volume 
(MVV) on bladder diary to determine the decreased nocturnal bladder capacity 
(NBC). However, it might be unreasonable because a study found the enuretic 
bladder capacity of enuresis children was significantly less than their daytime 
functional bladder capacity (FBC), while healthy children’s NBC was the same as 
FBC [62]. Kim et al.’s study also showed that the proportion of NE children with 
small NBC and small MVV was quite different. The accuracy using decreased 
MVV to identify small NBC is only medium to low [63]. Another study per-
formed by Borg et al. measured the difference in diaper weight between the early 
part and the later part of the night, as the enuretic bladder capacity, in MNE chil-
dren with normal MVV, and found that 82% of children had less bladder capacity 
than MVV during enuresis, even less than 65% of expected bladder capacity 
[64]. These studies indicate that although small MVV can be used to determine 
the reduction of FBC, it cannot assess accurately NBC or enuretic bladder capac-
ity. If pediatricians manage MNE children with normal MVV with desmopressin 
following the ICCS guidelines, these children may still experience nocturnal 
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enuresis due to a mismatch between bladder capacity and urine volume at night. 
Therefore, a new method for assessing NBC and enuretic bladder capacity needs 
to be explored.
Barroso et al. assessed the efficacy of a new device, which is the combina-
tion of alarm and electrical stimulation to the pelvic floor muscles, for NE. This 
device presented an advantage that helps children to achieve no wet beds dur-
ing the period of treatment. On the one hand, pelvic floor muscle contraction 
induced by electrical stimulus may cause an increased urethral closure pressure, 
which allows children to keep dry during nighttime. On the other hand, alarm 
would also be triggered by the humidity sensor, and children would be waked to 
void [65]. This device needs more trials to determine its effectiveness and safety. 
Additionally, there was an intelligent autonomous alarm using ultrasound and 
smartphone ML techniques raised in 2019. It could monitor the bladder and trig-
ger before the voiding desire. It also has the advantage to achieve totally dry bed 
during treatment [66].
6. Conclusions
Standard therapy should be applied to every child when he first visits the clinic. 
Then clinicians follow the diagnosis algorithm to distinguish MNE from NMNE and 
determine which subtype the child is. According to the ICCS’s guideline [10], MNE 
children with normal nocturnal urine volume (normal or reduced MVV) should 
choose the alarm therapy. It is believed as the most effective single-therapy with the 
lower recurrence rate and has efficacy for most types of MNE, even NMNE. The 
addition of overlearning can reduce the relapse rate of alarm. Therefore, it is neces-
sary to perform overlearning after the success of the alarm treatment. Complex 
behavioral therapies supplemented by alarm are more effective than alarm and can 
reduce the recurrence rate. It can be advised to families with better motivation and 
seeking for better efficacy. Desmopressin should be used for the treatment of MNE 
children with polyuria (normal or reduced MVV). To avoid relapse, the drug can be 
taken for a long time and then gradually reduced.
The guideline recommended small MVV and NP children to use combination 
therapy of alarm and desmopressin [10]. The addition of alarm can increase the 
long-term efficacy of desmopressin [37]. However, combination therapy seems 
not to reduce the number of children who do not achieve 14 consecutive dry nights 
compared with alarm alone [29], indicating that patients who do not have full 
response to these two therapies may be mostly overlapped.
For refractory NE, clinicians should reassess children’s potential physiological 
malformations and neurogenic bladder diseases using MRI, urodynamics, cystos-
copy, urography, etc. if necessary. After first-line treatment failure, children with 
detrusor overactivity or decreasing functional bladder capacity can choose anti-
cholinergic drugs. Other children can choose tricyclic drugs, biofeedback therapy, 
electrical stimulation interventions, acupuncture, massage and so on, or a combina-
tion of first-line therapy and second-line therapy.
In summary, after meticulous diagnosis and assessment and appropriate treat-
ment with sufficient evidence, most MNE children can get a great relief or even cure.
Lower Urinary Tract Dysfunction - From Evidence to Clinical Practice
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